ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,747Medicare Part D Prescriptions Filled, Including Refills

Rank: 85 out of 2056

$450K Total Retail Price of All Prescriptions

Rank: 101 out of 2056

402 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
35% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

17% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 6,889 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
SIMVASTATIN 378 279 1 2
LISINOPRIL 311 265 2 1
AMLODIPINE BESYLATE 264 216 3 6
HYDROCODONE-ACETAMINOPHEN 262 203 S3 4 5
WARFARIN SODIUM 220 207 5 12
LEVOTHYROXINE SODIUM 218 164 6 3
OMEPRAZOLE 207 141 7 4
FUROSEMIDE 196 185 8 9
OXYCODONE HCL 177 71 S2 9 24
HYDROCHLOROTHIAZIDE 157 118 10 7
METOPROLOL TARTRATE 155 140 11 11
METFORMIN HCL 154 127 12 8
LOSARTAN POTASSIUM 152 135 13 13
CITALOPRAM HBR 144 113 14 15
LOVASTATIN 142 100 15 16
METOPROLOL SUCCINATE 139 122 16 19
ZOLPIDEM TARTRATE 131 104 17 23
MIRTAZAPINE 119 117 18 45
ALLOPURINOL 117 100 19 32
GABAPENTIN 116 97 20 14
METHADONE HCL 113 52 S2 21 49
PREDNISONE 113 110 21 38
ATENOLOL 112 95 23 10
GLIMEPIRIDE 101 89 24 67
ALENDRONATE SODIUM 95 91 25 26
METFORMIN HCL ER 79 74 26 43
CRESTOR 77 76 27 30
POTASSIUM CHLORIDE 76 76 28 18
DIOVAN 75 36 29 68
FLUTICASONE PROPIONATE 70 49 30 31
PROAIR HFA 68 37 31 29
OXYCODONE-ACETAMINOPHEN 67 34 S2 32 40
PRAVASTATIN SODIUM 66 57 33 20
CARVEDILOL 65 65 34 35
MORPHINE SULFATE ER 62 31 S2 35 36
CYCLOBENZAPRINE HCL 60 31 R 36 52
TRIAMTERENE-HCTZ 56 29 37 46
LANTUS 54 50 38 41
TERAZOSIN HCL 53 42 39 106
VENTOLIN HFA 52 25 40 109
LISINOPRIL-HYDROCHLOROTHIAZIDE 51 27 41 34
TRIAMCINOLONE ACETONIDE 51 41 41 81
DIGOXIN 50 50 43 53
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.